ClinicalTrials.Veeva

Menu

Sepsis: From Syndrome to Personalized Care

University of Oslo (UIO) logo

University of Oslo (UIO)

Status

Enrolling

Conditions

Sepsis Syndrome
Sepsis, Severe
Septic Shock
Sepsis

Study type

Observational

Funder types

Other

Identifiers

NCT04203979
Sepsis-OUH-2

Details and patient eligibility

About

This is a prospective, observational study designed to examine the performance of biomarkers, molecular biological methods and other analysis in blood from patient with suspected sepsis in the Emergency department, as well as identidying novel sepsis endotypes. Around 1500 patients will be enrolled.

Full description

The study will prospectively include adult patients (>18 years) with suspected sepsis admitted to Oslo University Hospital, Ullevål (OUH-Ullevål). Patients admitted to the emergency department and managed by the medical rapid response team or the sepsis rapid response team are considered eligible for inclusion. Informed consent will be collected at the emergency department if possible, or within few days, by a clinical investigator or a study nurse. The investigators aim to include 1500 patients treated by the Sepsis Rapid Response Team or Medical Emergency team for possible sepsis. Patients classified to have had other conditions than sepsis in the post hoc assessment will be used as controls. The inclusion period will be 3 years.

Enrollment

1,500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • admitted to emergency department OUH, Ullevål.
  • managed by the medical rapid response team or the sepsis rapid response team

Exclusion criteria

  • Not given informed consent by patient or next of kin (if patient is not able to)

Trial contacts and locations

1

Loading...

Central trial contact

Aleksander R Holten, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems